Roles of Rho-Associated Kinase and Oxidative Stress in the Pathogenesis of Aortic Stiffness

Journal of the American College of Cardiology

Volumn 49, Issue 6, 2007, Pages 698-705

  Noma, Kensuke ^a   Goto, Chikara ^a   Nishioka, Kenji ^a   Jitsuiki, Daisuke ^a   Umemura, Takashi ^a   Ueda, Keiko ^a   Kimura, Masashi ^a   Nakagawa, Keigo ^a   Oshima, Tetsuya ^a   Chayama, Kazuaki ^a   Yoshizumi, Masao ^a   Liao, James K ^b   Higashi, Yukihito ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ENDOTHELIUM DERIVED RELAXING FACTOR; FASUDIL; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; N(G) METHYLARGININE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; RHO KINASE; RHO KINASE INHIBITOR;

ADULT; AGING; AORTA DISEASE; ARTERY COMPLIANCE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY PULSE; DOSE RESPONSE; ENZYME ACTIVITY; FEMORAL ARTERY; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; OXIDATIVE STRESS; PLETHYSMOGRAPHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PULSE WAVE; SMOKING;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ACETYLCHOLINE; ADULT; AORTIC DISEASES; ATHEROSCLEROSIS; FOREARM; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NITRIC OXIDE DONORS; NITROPRUSSIDE; OXIDATIVE STRESS; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; REGIONAL BLOOD FLOW;

EID: 33846842317     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.06.082     Document Type: Article

References (39)

1. Horwitz A.R., and Parsons J.T. Cell migration-movin' on. Science 286 (1999) 1102-1103
2. Takemoto M., Sun J., Hiroki J., Shimokawa H., and Liao J.K. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 106 (2002) 57-62
3. Laufs U., and Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273 (1998) 24266-24271
4. Ming X.F., Viswambharan H., Barandier C., et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol 22 (2002) 8467-8477
5. Sawada N., Itoh H., Ueyama K., et al. Inhibition of Rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries. Circulation 101 (2000) 2030-2033
6. Uehata M., Ishizaki T., Satoh H., et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389 (1997) 990-994
7. Masumoto A., Mohri M., Shimokawa H., Urakami L., Usui M., and Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 105 (2002) 1545-1547
8. Masumoto A., Hirooka Y., Shimokawa H., Hironaga K., Setoguchi S., and Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38 (2001) 1307-1310
9. Shimokawa H., Hiramori K., Iinuma H., et al. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study. J Cardiovasc Pharmacol 40 (2002) 751-761
10. Noma K., Higashi Y., Jitsuiki D., et al. Smoking activates Rho-kinase in smooth muscle cells of forearm vasculature in humans. Hypertension 41 (2003) 1102-1105
11. Noma K., Goto C., Nishioka K., et al. Smoking, endothelial function, and Rho-kinase in humans. Arterioscler Thromb Vasc Biol 25 (2005) 2630-2635
12. Kureishi Y., Kobayashi S., Amano M., et al. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem 272 (1997) 12257-12260
13. Somlyo A.P., and Somlyo A.V. Signal transduction and regulation in smooth muscle. Nature 372 (1994) 231-236
14. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., and Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24 (1994) 471-476
15. Heitzer T., Schlinzig T., Krohn K., Meinertz T., and Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104 (2001) 2673-2678
16. Wolfrum S., Dendorfer A., Rikitake Y., et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol 24 (2004) 1842-1847
17. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
18. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Oshima T., and Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 346 (2002) 1954-1962
19. Jin L., Ying Z., and Webb R.C. Activation of Rho/Rho kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol 287 (2004) H1495-H1500
20. Bailey S.R., Mitra S., Flavahan S., and Flavahan N.A. Reactive oxygen species from smooth muscle mitochondria initiate cold-induced constriction of cutaneous arteries. Am J Physiol Heart Circ Physiol 289 (2005) H243-H250
21. Blacher J., Guerin A.P., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
22. de Simone G., Roman M.J., Koren M.J., Mensah G.A., Ganau A., and Devereux R.B. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension 33 (1999) 800-805
23. Avolio A., Jones D., and Tafazzoli-Shadpour M. Quantification of alterations in structure and function of elastin in the arterial media. Hypertension 32 (1998) 170-175
24. Kimoto E., Shoji T., Shinohara K., et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 52 (2003) 448-452
25. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
26. Jin L., Liu T., Lagoda G.A., Champion H.C., Bivalacqua T.J., and Burnett A.L. Elevated RhoA/Rho-kinase activity in the aged rat penis: mechanism for age-associated erectile dysfunction. Faseb J (2006)
27. Miao L., Calvert J.W., Tang J., Parent A.D., and Zhang J.H. Age-related RhoA expression in blood vessels of rats. Mech Ageing Dev 122 (2001) 1757-1770
28. Nagumo H., Sasaki Y., Ono Y., Okamoto H., Seto M., and Takuwa Y. Rho kinase inhibitor HA-1077 prevents Rho-mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 278 (2000) C57-C65
29. Kishi T., Hirooka Y., Masumoto A., et al. Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure. Circulation 111 (2005) 2741-2747
30. Lehmann E.D., Watts G.F., and Gosling R.G. Aortic distensibility and hypercholesterolaemia. Lancet 340 (1992) 1171-1172
31. Wiesmann F., Petersen S.E., Leeson P.M., et al. Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high-resolution magnetic resonance imaging. J Am Coll Cardiol 44 (2004) 2056-2064
32. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
33. Willum-Hansen T., Staessen J.A., Torp-Pedersen C., et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113 (2006) 664-670
34. Boaz M., Smetana S., Weinstein T., et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356 (2000) 1213-1218
35. Mourad J.J., Pannier B., Blacher J., et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 59 (2001) 1834-1841
36. Esposito K., Marfella R., Ciotola M., et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292 (2004) 1440-1446
37. Safar M.E., Thomas F., Blacher J., et al. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 47 (2006) 72-75
38. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
39. Nakakuki T., Ito M., Iwasaki H., et al. Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25 (2005) 2088-2093